• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于测量神经病变靶标酯酶活性的纳米结构生物传感器。

Nanostructured biosensor for measuring neuropathy target esterase activity.

作者信息

Kohli Neeraj, Srivastava Devesh, Sun Jun, Richardson Rudy J, Lee Ilsoon, Worden Robert M

机构信息

Department of Chemical Engineering and Materials Science, Michigan State University, East Lansing, Michigan 48824, USA.

出版信息

Anal Chem. 2007 Jul 15;79(14):5196-203. doi: 10.1021/ac0701684. Epub 2007 Jun 8.

DOI:10.1021/ac0701684
PMID:17555296
Abstract

Neuropathy target esterase (NTE) is a membrane protein found in human neurons and other cells, including lymphocytes. Binding of certain organophosphorus (OP) compounds to NTE is believed to cause OP-induced delayed neuropathy (OPIDN), a type of paralysis for which there is no effective treatment. Mutations in NTE have also been linked with serious neurological diseases, such as motor neuron disease. This paper describes development of the first nanostructured biosensor interface containing a catalytically active fragment of NTE known as NEST. The biosensor was fabricated using the layer-by-layer assembly approach, by immobilizing a layer of NEST on top of multilayers consisting of a polyelectrolyte (poly-L-lysine) and an enzyme (tyrosinase). The biosensor has a response time on the order of seconds and gives a concentration-dependent decrease in sensor output in response to a known NEST (and NTE) inhibitor. Potential applications of the biosensor include screening OP compounds for NTE inhibition and investigating the enzymology of wild-type and mutant forms of NTE. Although the development of a NEST biosensor was the primary purpose of this study, we found that the approach developed for NEST could also be extended to measure the activity of other esterases involved in neural processes, such as acetylcholinesterase (AChE) and butyrylcholinesterase (BChE). On the basis of measured sensitivities, phenyl valerate was the preferred substrate for NEST and BChE, whereas phenyl acetate was better for AChE.

摘要

神经病靶酯酶(NTE)是一种存在于人类神经元和其他细胞(包括淋巴细胞)中的膜蛋白。某些有机磷(OP)化合物与NTE的结合被认为会导致OP诱导的迟发性神经病(OPIDN),这是一种尚无有效治疗方法的瘫痪类型。NTE的突变也与严重的神经疾病有关,如运动神经元病。本文描述了首个包含NTE催化活性片段(称为NEST)的纳米结构生物传感器界面的开发。该生物传感器采用逐层组装方法制造,通过将一层NEST固定在由聚电解质(聚-L-赖氨酸)和酶(酪氨酸酶)组成的多层膜之上。该生物传感器的响应时间在秒级,并且响应已知的NEST(和NTE)抑制剂时,传感器输出会呈现浓度依赖性下降。该生物传感器的潜在应用包括筛选抑制NTE的OP化合物以及研究野生型和突变型NTE的酶学。尽管开发NEST生物传感器是本研究的主要目的,但我们发现为NEST开发的方法也可以扩展到测量参与神经过程的其他酯酶的活性,如乙酰胆碱酯酶(AChE)和丁酰胆碱酯酶(BChE)。根据测量的灵敏度,戊酸苯酯是NEST和BChE的首选底物,而乙酸苯酯对AChE更合适。

相似文献

1
Nanostructured biosensor for measuring neuropathy target esterase activity.用于测量神经病变靶标酯酶活性的纳米结构生物传感器。
Anal Chem. 2007 Jul 15;79(14):5196-203. doi: 10.1021/ac0701684. Epub 2007 Jun 8.
2
Biosensor detection of neuropathy target esterase in whole blood as a biomarker of exposure to neuropathic organophosphorus compounds.生物传感器检测全血中的神经病变靶标酯酶,作为接触神经性有机磷化合物的生物标志物。
J Toxicol Environ Health A. 2003 Apr 11;66(7):599-610. doi: 10.1080/15287390309353769.
3
Biosensor assay of neuropathy target esterase in whole blood as a new approach to OPIDN risk assessment: review of progress.全血中神经病靶酯酶的生物传感器检测作为有机磷中毒迟发性神经病风险评估的新方法:进展综述
Hum Exp Toxicol. 2007 Apr;26(4):273-82. doi: 10.1177/0960327106070463.
4
A new approach for determination of neuropathy target esterase activity.一种测定神经病变靶酯酶活性的新方法。
Chem Biol Interact. 1999 May 14;119-120:559-65. doi: 10.1016/s0009-2797(99)00070-8.
5
Constructs of human neuropathy target esterase catalytic domain containing mutations related to motor neuron disease have altered enzymatic properties.与人神经病靶酯酶催化结构域相关的突变导致运动神经元疾病的构建体改变了酶的特性。
Toxicol Lett. 2010 Jul 1;196(2):67-73. doi: 10.1016/j.toxlet.2010.03.1120. Epub 2010 Apr 9.
6
Neuropathy target esterase in mouse whole blood as a biomarker of exposure to neuropathic organophosphorus compounds.小鼠全血中的神经病靶酯酶作为接触神经性有机磷化合物的生物标志物。
J Appl Toxicol. 2016 Nov;36(11):1468-75. doi: 10.1002/jat.3305. Epub 2016 Mar 11.
7
Interactions of human acetylcholinesterase with phenyl valerate and acetylthiocholine: Thiocholine as an enhancer of phenyl valerate esterase activity.人乙酰胆碱酯酶与苯戊酸和乙酰硫代胆碱的相互作用:硫代胆碱作为苯戊酸酯酶活性的增强剂。
Chem Biol Interact. 2022 Jan 5;351:109764. doi: 10.1016/j.cbi.2021.109764. Epub 2021 Dec 4.
8
Influence of lysophospholipid hydrolysis by the catalytic domain of neuropathy target esterase on the fluidity of bilayer lipid membranes.神经病靶标酯酶催化结构域对溶血磷脂水解作用对双层脂质膜流动性的影响。
Biochim Biophys Acta. 2010 Aug;1798(8):1533-9. doi: 10.1016/j.bbamem.2010.03.015. Epub 2010 Mar 25.
9
Comparative studies of O,O-dialkyl-O-chloromethylchloroformimino phosphates: interaction with neuropathy target esterase and acetylcholinesterase.O,O-二烷基-O-氯甲基氯代甲亚胺基磷酸酯的比较研究:与神经病变靶酯酶和乙酰胆碱酯酶的相互作用
Neurotoxicology. 1998 Aug-Oct;19(4-5):623-8.
10
Improved electrochemical analysis of neuropathy target esterase activity by a tyrosinase carbon paste electrode modified by 1-methoxyphenazine methosulfate.通过硫酸甲酯吩嗪修饰的酪氨酸酶碳糊电极改进对神经病变靶标酯酶活性的电化学分析。
Biotechnol Lett. 2005 Aug;27(16):1211-8. doi: 10.1007/s10529-005-0020-1.

引用本文的文献

1
Electrochemical Biosensor for Markers of Neurological Esterase Inhibition.用于神经酯酶抑制标志物的电化学生物传感器。
Biosensors (Basel). 2021 Nov 16;11(11):459. doi: 10.3390/bios11110459.
2
Integrated Experimental and Theoretical Studies on an Electrochemical Immunosensor.电化学免疫传感器的综合实验与理论研究。
Biosensors (Basel). 2020 Oct 17;10(10):144. doi: 10.3390/bios10100144.
3
Neuropathy target esterase (NTE/PNPLA6) and organophosphorus compound-induced delayed neurotoxicity (OPIDN).神经病变靶酯酶(NTE/PNPLA6)与有机磷化合物诱导的迟发性神经毒性(OPIDN)。
Adv Neurotoxicol. 2020;4:1-78. doi: 10.1016/bs.ant.2020.01.001. Epub 2020 Mar 3.
4
Constructs of human neuropathy target esterase catalytic domain containing mutations related to motor neuron disease have altered enzymatic properties.与人神经病靶酯酶催化结构域相关的突变导致运动神经元疾病的构建体改变了酶的特性。
Toxicol Lett. 2010 Jul 1;196(2):67-73. doi: 10.1016/j.toxlet.2010.03.1120. Epub 2010 Apr 9.